- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Oxaliplatin market will register a 2.1% CAGR in terms of revenue, the global market size will reach $ 901.4 million by 2025, from $ 830.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Oxaliplatin business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Oxaliplatin market by type, application, key manufacturers and key regions and countries.
This study considers the Oxaliplatin value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Mannitol
Glucose Solution
Lactose Solution
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi-Aventis
Nanjing Pharmaceutical Factory
Yakult honsha
Sun Pharmaceutical
Teva
Dr Reddy's laboratories
Mylan
Fresenius Kabi
Jiangsu Hengrui Medicine
Hospira
Halfsky Pharmacy
Hainan Jinrui Pharmaceutical
YRPG
Jiangsu Aosaikang Pharmaceutical
Lunan Pharmaceutical
Hisun Pharmaceutical
Chiatai Tianqing
Luoxin
Qilu Pharmaceutical
Jari Pharmaceutical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Oxaliplatin consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Oxaliplatin market by identifying its various subsegments.
Focuses on the key global Oxaliplatin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oxaliplatin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Oxaliplatin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oxaliplatin Consumption 2015-2025
2.1.2 Oxaliplatin Consumption CAGR by Region
2.2 Oxaliplatin Segment by Type
2.2.1 Mannitol
2.2.2 Glucose Solution
2.2.3 Lactose Solution
2.2.4 Other
2.3 Oxaliplatin Consumption by Type
2.3.1 Global Oxaliplatin Consumption Market Share by Type (2015-2020)
2.3.2 Global Oxaliplatin Revenue and Market Share by Type (2015-2020)
2.3.3 Global Oxaliplatin Sale Price by Type (2015-2020)
2.4 Oxaliplatin Segment by Application
2.4.1 Colorectal Cancer
2.4.2 Stomach Cancer
2.4.3 Ovarian Cancer
2.4.4 Other
2.5 Oxaliplatin Consumption by Application
2.5.1 Global Oxaliplatin Consumption Market Share by Type (2015-2020)
2.5.2 Global Oxaliplatin Value and Market Share by Type (2015-2020)
2.5.3 Global Oxaliplatin Sale Price by Type (2015-2020)
3 Global Oxaliplatin by Company
3.1 Global Oxaliplatin Sales Market Share by Company
3.1.1 Global Oxaliplatin Sales by Company (2018-2020)
3.1.2 Global Oxaliplatin Sales Market Share by Company (2018-2020)
3.2 Global Oxaliplatin Revenue Market Share by Company
3.2.1 Global Oxaliplatin Revenue by Company (2018-2020)
3.2.2 Global Oxaliplatin Revenue Market Share by Company (2018-2020)
3.3 Global Oxaliplatin Sale Price by Company
3.4 Global Oxaliplatin Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Oxaliplatin Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Oxaliplatin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Oxaliplatin by Regions
4.1 Oxaliplatin by Regions
4.2 Americas Oxaliplatin Consumption Growth
4.3 APAC Oxaliplatin Consumption Growth
4.4 Europe Oxaliplatin Consumption Growth
4.5 Middle East & Africa Oxaliplatin Consumption Growth
5 Americas
5.1 Americas Oxaliplatin Consumption by Countries
5.1.1 Americas Oxaliplatin Consumption by Countries (2015-2020)
5.1.2 Americas Oxaliplatin Value by Countries (2015-2020)
5.2 Americas Oxaliplatin Consumption by Type
5.3 Americas Oxaliplatin Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Oxaliplatin Consumption by Regions
6.1.1 APAC Oxaliplatin Consumption by Regions (2015-2020)
6.1.2 APAC Oxaliplatin Value by Regions (2015-2020)
6.2 APAC Oxaliplatin Consumption by Type
6.3 APAC Oxaliplatin Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Oxaliplatin by Countries
7.1.1 Europe Oxaliplatin Consumption by Countries (2015-2020)
7.1.2 Europe Oxaliplatin Value by Countries (2015-2020)
7.2 Europe Oxaliplatin Consumption by Type
7.3 Europe Oxaliplatin Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Oxaliplatin by Countries
8.1.1 Middle East & Africa Oxaliplatin Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Oxaliplatin Value by Countries (2015-2020)
8.2 Middle East & Africa Oxaliplatin Consumption by Type
8.3 Middle East & Africa Oxaliplatin Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Oxaliplatin Distributors
10.3 Oxaliplatin Customer
11 Global Oxaliplatin Market Forecast
11.1 Global Oxaliplatin Consumption Forecast (2021-2025)
11.2 Global Oxaliplatin Forecast by Regions
11.2.1 Global Oxaliplatin Forecast by Regions (2021-2025)
11.2.2 Global Oxaliplatin Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Oxaliplatin Forecast by Type
11.8 Global Oxaliplatin Forecast by Application
12 Key Players Analysis
12.1 Sanofi-Aventis
12.1.1 Company Information
12.1.2 Oxaliplatin Product Offered
12.1.3 Sanofi-Aventis Oxaliplatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Sanofi-Aventis Latest Developments
12.2 Nanjing Pharmaceutical Factory
12.2.1 Company Information
12.2.2 Oxaliplatin Product Offered
12.2.3 Nanjing Pharmaceutical Factory Oxaliplatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Nanjing Pharmaceutical Factory Latest Developments
12.3 Yakult honsha
12.3.1 Company Information
12.3.2 Oxaliplatin Product Offered
12.3.3 Yakult honsha Oxaliplatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Yakult honsha Latest Developments
12.4 Sun Pharmaceutical
12.4.1 Company Information
12.4.2 Oxaliplatin Product Offered
12.4.3 Sun Pharmaceutical Oxaliplatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Sun Pharmaceutical Latest Developments
12.5 Teva
12.5.1 Company Information
12.5.2 Oxaliplatin Product Offered
12.5.3 Teva Oxaliplatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Teva Latest Developments
12.6 Dr Reddy's laboratories
12.6.1 Company Information
12.6.2 Oxaliplatin Product Offered
12.6.3 Dr Reddy's laboratories Oxaliplatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Dr Reddy's laboratories Latest Developments
12.7 Mylan
12.7.1 Company Information
12.7.2 Oxaliplatin Product Offered
12.7.3 Mylan Oxaliplatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Mylan Latest Developments
12.8 Fresenius Kabi
12.8.1 Company Information
12.8.2 Oxaliplatin Product Offered
12.8.3 Fresenius Kabi Oxaliplatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Fresenius Kabi Latest Developments
12.9 Jiangsu Hengrui Medicine
12.9.1 Company Information
12.9.2 Oxaliplatin Product Offered
12.9.3 Jiangsu Hengrui Medicine Oxaliplatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Jiangsu Hengrui Medicine Latest Developments
12.10 Hospira
12.10.1 Company Information
12.10.2 Oxaliplatin Product Offered
12.10.3 Hospira Oxaliplatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Hospira Latest Developments
12.11 Halfsky Pharmacy
12.11.1 Company Information
12.11.2 Oxaliplatin Product Offered
12.11.3 Halfsky Pharmacy Oxaliplatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Halfsky Pharmacy Latest Developments
12.12 Hainan Jinrui Pharmaceutical
12.12.1 Company Information
12.12.2 Oxaliplatin Product Offered
12.12.3 Hainan Jinrui Pharmaceutical Oxaliplatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Hainan Jinrui Pharmaceutical Latest Developments
12.13 YRPG
12.13.1 Company Information
12.13.2 Oxaliplatin Product Offered
12.13.3 YRPG Oxaliplatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 YRPG Latest Developments
12.14 Jiangsu Aosaikang Pharmaceutical
12.14.1 Company Information
12.14.2 Oxaliplatin Product Offered
12.14.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Jiangsu Aosaikang Pharmaceutical Latest Developments
12.15 Lunan Pharmaceutical
12.15.1 Company Information
12.15.2 Oxaliplatin Product Offered
12.15.3 Lunan Pharmaceutical Oxaliplatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Lunan Pharmaceutical Latest Developments
12.16 Hisun Pharmaceutical
12.16.1 Company Information
12.16.2 Oxaliplatin Product Offered
12.16.3 Hisun Pharmaceutical Oxaliplatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Hisun Pharmaceutical Latest Developments
12.17 Chiatai Tianqing
12.17.1 Company Information
12.17.2 Oxaliplatin Product Offered
12.17.3 Chiatai Tianqing Oxaliplatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Chiatai Tianqing Latest Developments
12.18 Luoxin
12.18.1 Company Information
12.18.2 Oxaliplatin Product Offered
12.18.3 Luoxin Oxaliplatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Luoxin Latest Developments
12.19 Qilu Pharmaceutical
12.19.1 Company Information
12.19.2 Oxaliplatin Product Offered
12.19.3 Qilu Pharmaceutical Oxaliplatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Qilu Pharmaceutical Latest Developments
12.20 Jari Pharmaceutical
12.20.1 Company Information
12.20.2 Oxaliplatin Product Offered
12.20.3 Jari Pharmaceutical Oxaliplatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Jari Pharmaceutical Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Oxaliplatin Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Mannito
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
